Abstract
Objective Previous studies have reported the expansion of CD19+Siglec-10+ B cells in systemic lupus erythematosus (SLE) patients. However, the composition of this cell population, phenotype and characteristics are still unknown. Methods We examined this memory B-cell subset’s composition and phenotype and determined the SYK and AKT phosphorylation levels by flow cytometry. Additionally, we explored the relationship between Siglec-10 expression on B-cell subsets and clinical manifestations. Results Our results indicated elevated levels of Siglec-10 on naive B cells in active SLE patients. Compared with healthy controls (HCs) and inactive SLE patients, the Siglec-10+ B cells in active SLE patients exhibited elevated CD40 and CD21low levels. The levels of Siglec-10 on naive B cells were positively correlated with the proportion of CD21low double negative (DN) B cells and the SLEDAI-2K score. Conclusion The results indicate that the upregulation of Siglec-10+/naive B cells may function as a feedback mechanism to regulate B cell hyperreactivity. Monitoring the proportion of Siglec-10+/naive B cells may contribute to the evaluation of disease progression in SLE.
| Original language | English |
|---|---|
| Pages (from-to) | 507-516 |
| Number of pages | 10 |
| Journal | Clinical and Experimental Rheumatology |
| Volume | 43 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2025 |
Keywords
- B-cell subsets
- autoreactive B cells
- biomarker
- sialic acid binding Ig like lectin 10
- systemic lupus erythematosus
Fingerprint
Dive into the research topics of 'The expression of Siglec-10 on naive B cells is involved in the pathology of systemic lupus erythematosus'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver